Home | Volume 36 | Article number 322


The prevalence of positive rapid diagnostic test of hepatitis C virus infection in Ghana

The prevalence of positive rapid diagnostic test of hepatitis C virus infection in Ghana

Masood Maleki Birjandi1, Mahbobeh Oroei2,&


1Polyclinic, Iranian Red Crescent Society, Accra, Ghana, 2Hearing Disorders Reseach Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran



&Corresponding author
Mahbobeh Oroei, Hearing Disorders Reseach Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran




Introduction: hepatitis C virus (HCV) infection is one of the most common viral hepatitis in Africa. Rapid diagnostic test (RDT) is a useful tool to identify antibody anti-HCV in point of care. In this study, we decided to determine prevalence of cases with positive rapid diagnostic test of HCV infection.


Methods: this cross-sectional study was conducted in a polyclinic, Accra, Ghana. Using convenience sampling, 728 participants were screened with blood-based RDT and interviewed about personal risk behaviors for transmission of HCV. Data was entered in SPSS version 18 and analyzed.


Results: there was 1.6% positive RDT in our participants. The mean age of them was 29.58 ± 12.31 years old that were younger than the participants with negative RDT (p: 0.027). The rate of positive test was 66.67% in women and 33.33% in men. There was a negative association between age and RDT positive (aOR: 0.91, 95%CI 0.85-0.96). The odds of positive RDT in married participants was 6.32 fold others after adjusting model (p: 0.014). There were no important risk behavior for HCV, except one person with history of contacting blood or needles.


Conclusion: the risk of positive RDT has a reverse relationship with aging and also it has an increase in married individuals. Therefore preventive education and screening for HCV should be a priority in young and middle-aged adults because of more sexual activity.



Introduction    Down

Hepatitis C virus (HCV) is one of the most common cause of chronic liver infection that can lead to persistent HCV, cirrhosis (15-30%), hepatocellular carcinoma (2-4% annually), liver failure, and death [1, 2]. Almost a quarter of liver cirrhosis and hepatocellular carcinoma are attributable to HCV that are higher rate in endemic regions [3]. The prevalence of HCV is between 2% and 3% in global, and out of 70 million patients have active viraemia. The burden of HCV infection is significant in developing countries due to poor control management (screening, treatment and protective behaviors) [4, 5]. The first action fighting for HCV is early detection. The screening procedures of it are based on to discover antibody anti-HCV in the suspected individuals that including rapid diagnostic test (RDT) and laboratory-based immunoassay. The final purpose of screening is to confirm viremia and core antigen of HCV (HCVcAg) or HCV RNA in blood or body fluids after positive RDT [2]. World Health Organisation recommends RDT as point-of-care testing for large scale population. This test is a cost effectiveness, and feasibility test in screening of viral hepatitis [6-8] and can be blood or saliva-based that both have good sensitivity and specificity compared to gold standard test [9]. All patients with positive RDT should be investigated with nucleic acid test (NAT) to detect RNA of HCV, because of HCV infection clears spontaneously in 15-45% cases [10-12]. The main routes of HCV transmission include using needles or other equipment that are infected with the blood of a person infected with HCV, being born to a mother infected HCV, getting a tattoo or body piercing in an unregulated setting, infected blood products with HCV and sexual transmission [13].

The seroprevalence of HCV in Africa is more than other regions globally [3, 13]. It was estimated 3% (2.6%-3.5%) in Ghana, so that regional seroprevalence of HCV was 6.4% (4.2%-8.6%) in Accra [14]. One of the most predominant for HCV transmission, especially in western Africa is unsafe sexual contact with a person infected with HCV [15], but some studies showed sexual transmission in HCV infection is controversial [13, 16]. It is certainly that unsafe medical procedures are the main route of transmission HCV in regions with poor facilities [14, 17]. However, we decided to design this study to investigate seroprevalence of HCV among the patients referred to our polyclinic in Accra and to determine personal risk factors in them.



Methods Up    Down

This cross-sectional study was conducted on patients of polyclinic, Accra, Ghana in 2019. The sample size was estimated at least 385 using the prevalence estimation formula with 90% confidence level, 0.05% accuracy and 50% prevalence [18]. The inclusion criteria of the patients were as follows: both genders who were not the known case of hepatitis and were aged 18 years or more, outpatients of the polyclinic, and able in participating in this study. We prepared a questionnaire using comprehensive literature review for data collection. The content validity of questionnaire was conducted by two authors. The variables of questionnaire were about risk agents of HCV transmission, and sociodemographic information of the patients. Based on conveninece sampling, 728 patients were investigated during one year. All were screened with blood-based RDT and then interviewed with questionnaire study. Data was entered in SPSS version 18 and the statistical tests such as Chi-square test, and independent t test, and also Mann Whitney test (for skewed data) were applied. Also we used univariate and multivariate logistic regression to find odds positive RDT. The significance level of statistical tests was set at below 0.05 and 95% confidence intervals were calculated for unadjusted and adjusted odds ratios. This study was conducted according to the Declaration of Helsinki and ensured the patients that their personal and medical information would be kept confidential. Informed consent was obtained from all patients. The study protocols were confirmed by the Health and Rehabilitation Deputy of Iranian Red Crescent Society in 2019 and were in line with the humanitarian services of the Iranian Red Crescent Society at polyclinic in Ghana.



Results Up    Down

We used a screening test for 728 patients from July 2019 through September 2019 at polyclinic, Accra. They consisted of male: 254(34.85%), female: 474(65.15%) and average age was 39.64 ± 16.72 years old that males were younger than females (37.94 ± 16.80, 40.55 ± 16.62 respectively, p: 0.017). The majority of the patients were non-smokers (97.94%), non-alcohol users (88.32%) and being literate (75.69%) (Table 1). Table 2 shows the percentage of identified risk agents of HCV in the patients. We had 145(19.92%) persons with a history of testing HIV, 74(10.16%) persons with testing HBV and 4(0.55%) with testing HCV in the past year. The most common risk agents in patients were respectively history of sexually transmitted infections (STI) (9.23%), blood transfusion (6.18%), body piercing/tattoo (5.63%), exposure to blood/ blood products/ needles (5.49%) and having multi-partner in the last year (3.30%). In screening of HCV with RDT, there was 12(1.6%) positive RDT. The mean age of them was 29.58 ± 12.31 years old that were younger than other patients (p: 0.027). The patients with positive RDT were 66.70% (n = 8) female, 66.70% (n = 8) married, 33.30% (n = 4) were illiterate, 66.70%(6 from 9) were self-employed and were no alcohol user and smoker and also had no medical history of diseases. There were no important risk agents of HCV in the patients with positive RDT, only one person had a history of contacting blood or needles. Respectively, two and one patients from them had a history of doing HIV and HBV tests that were negative responses. All patients with positive RDT were referred for counseling and treatment to more equipped centers. Table 3 shows relationships among some variables and gender. There was no significant relationship between gender and positive RDT (p: 1.00). Male patients had a higher rate of blood transfusion before 1992, multiple partners, a history of STD, and being imprisoned (p < 0.001). There was a significantly negative association between age and positive RDT in unadjusted and adjusted models (Table 4). In the adjusted model, odds of positive RDT in the married patients was almost 6-fold others (aOR 6.32; 95% confidence interval: 1.46-27.30).



Discussion Up    Down

In this study, we found 12 patients with positive RDT that the majority had no identified risk agents for HCV and were female and young. The odds of RDT positive in married patients was almost six-fold higher than other patients and with increasing age trend, its risk had decreased. Prevalence of positive RDT of our study was in line with Lokpo study [19] but it was different from other studies due to study population and age group. Apea-Kubi et al. [20] and Ephraim et al. [21] studied pregnant or non-pregnant women and reported higher positive test than us and Allain et al. [22] studied blood donors and found lower than.

Ghana as one of sub-Saharan Africa countries carries a significant portion of the prevalence of viral hepatitis, especially HCV infections, so that its prevalence was estimated higher than other regions of Africa except Burkina Faso, Benin, Cameroon, Gabon, and Angola [13]. HCV infection mostly transmite from blood and blood products (typically before 1990), unsafe injection and medical procedures, intravenous drug use, organ transplants, needle-stick injuries, body piercings/tattoo, and vertical transmission. The sexual transmission is controversial among heterosexual couples, but it is an important route in HIV positive men who have sex with men (MSM) and recreational drug users [16, 23]. HCV infection can be co-infection with HIV or HBV due to common risk behaviors. The prevalence co-infection HIV/HCV is lower than HIV/HBV. The co-infection of these viral diseases induce aggregative complications and side effects of antiviral therapies [24-26]. Co-infection of HCV with HIV was reported 5.7% in Platt´s study [5] and 0.4% in Loarec´s study [27]. In our study, there was no positive history of HBV or HIV in the patients with positive RDT. RDT is a feasible and rapid test for HCV infection that anti-HCV detects in blood or saliva samples of patients. This diagnostic tool has excellent sensitivity and specificity as compared to all HCV enzyme immunoassay antibody tests. Tang et al. reported sensitivity 97% and specificity 100% [9]. RDT has no cross-reaction with some immunoglobulins and antigens such as HBSAg, Anti-HBS, and rheumatoid factor [28], but may be false-positive in patients with schistosomiasis [29, 30]. Our study showed aging as a protective factor that it is explainable with decline sexual desire and activity [31], and also against married people have more risk. We found positive RDT in the patients with age before 60 years old and in female patients was more common than male patients similar to Lokpo's study and Niu's study [19, 32]. Based on our knowledge, it is improbable to transmit from blood products, because Ghana has a national policy for controlling blood-borne viral infections among blood donors [14]. One of the main transmit routes is unsafe medical procedures/injections that we didn't have enough information for judgment.

We found history of STI as the most common risk agent in self-reporting of our patient, but Akyar et al. reported body piercing and infection at birth as common risk factors [15], that we didn´t find. In line with evidence, we had more prevalence of using illicit drugs as a risk factor in men than women [33, 34], but did not observe positive RDT in the illicit drug users and patients with history of STI. Despite the common transmission pathways among HIV, HBV, and HCV infections, our study population had the history of HIV test more than other viral tests. This finding shows that the most health programs of Ghana have been devoted to combating HIV/AIDS and paid less attention to HCV infection. National and international evidence from Ghana comprises an increasing concern to high prevalence of HCV infection and its outcomes and also risk of co-infection HIV and HCV [14, 26, 35], therefore it is suggested a targeted screening program for these viruses in a form integrated rapid diagnostic test. Our findings showed that men had more multiple partners and STI than women. It is necessary men should be had a faithful monogamous relationship and refrained from sexual risk behaviors, to reduce the direct transmission of HCV in women and also indirectly in vertical transmission. It is not currently available vaccination for HCV infection in the world, while antiviral treatment exists that can be considered based on the type of HCV genome. The best practice against HCV infection is doing two important actions that include: 1) early identification and treat infected patients, 2) promoting level of awareness and attitude about routes of transmission of HCV infection in community.

Limitations: there are three limitations to our study. 1) Our study was not conducted multicenter and we only investigated a part of the population of Ghana that was referred to our polyclinic; 2) we didn´t screen other viral diseases (HBV, HIV) together HCV; 3) female patients were not questioned or tested in terms of pregnancy. We suggest a study with multistage sampling in rural and urban communities in which indices of viral hepatitis are measured in various subgroups population with considering pregnant women and children.

Funding: this study was funded by polyclinic in Accra, Ghana (the Deputy of Health and Rehabilitation of the Red Crescent Society of the Islamic Republic of Iran).



Conclusion Up    Down

It seems that aging reduces the risk of positive RDT, in other words, married people with a middle or young age have a more likely positive test due to more sexual activity. Therefore comprehensive preventive education and screening with RDT are recommended in those adults as integration into the primary health care of Africa countries.

What is known about this topic

  • The prevalence of HCV is significant in developing countries as African countries;
  • The rapid diagnostic test is a useful tool to identify HCV in point of care;
  • The screening of HCV is cost-benefit in controlling its complications.

What this study adds

  • The probability of positive RDT decreases with aging;
  • The probability of positive RDT is more in married individuals than others;
  • The most common individual risk factor is a positive history of sexually transmitted infections.



Competing interests Up    Down

The authors declare no competing interests.



Authors' contributions Up    Down

Authors conceived idea, with support from polyclinic in Accra, Ghana (the Deputy of Health and Rehabilitation of the Red Crescent Society of the Islamic Republic of Iran). The authors had data collection, supervision, data analysis, interpretation, literature search, writing, and critical review. All the authors read and approved the final version of the manuscript.



Acknowledgments Up    Down

The authors sincerely acknowledge the corporation of polyclinic of Iranian Red Crescent Society in Accra, the International Federation of Red Cross and Red Crescent Societies in Ghana.



Tables Up    Down

Table 1: baseline characteristics of the patients (n=728)

Table 2: the frequency percentage of risk agents for HCV infection in the 728 patients

Table 3: comparison of some variables based on gender

Table 4: univariate and multivariate logistic regression for predicting positive RDT



References Up    Down

  1. Organization World Health. Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection Updated Version April 2016. Guidelines: World Health Organization. 2016. Google Scholar

  2. Hellard Margaret E, Chou Roger, Easterbrook Philippa. WHO guidelines on testing for hepatitis B and C-meeting targets for testing. BioMed Central. 2017. PubMed | Google Scholar

  3. Averhoff Francisco M, Glass Nancy, Holtzman Deborah. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clinical infectious diseases. 2012;55(suppl_1):S10-S5. PubMed | Google Scholar

  4. Lavanchy Daniel. Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection. 2011;17(2):107-15. PubMed | Google Scholar

  5. Platt Lucy, Easterbrook Philippa, Gower Erin, McDonald Bethan, Sabin Keith, McGowan Catherine et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. The Lancet infectious diseases. 2016;16(7):797-808. PubMed | Google Scholar

  6. Sharafi H, Poustchi H, Azimian F, Tamadoni B, Ramezani R, Gouya MM et al. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2019;113:20-3. PubMed | Google Scholar

  7. Organization World Health. WHO guidelines on hepatitis B and C testing. World Health Organization. 2017. Google Scholar

  8. Leathers JS, Pisano MB, Re V, van Oord G, Sultan A, Boonstra A et al. Validation of a point-of-care rapid diagnostic test for hepatitis C for use in resource-limited settings. International health. 2019. PubMed | Google Scholar

  9. Tang Weiming, Chen Wen, Amini Ali, Boeras Debi, Falconer Jane, Kelly Helen et al. Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature. BMC infectious diseases. 2017;17(Suppl 1):695-. PubMed | Google Scholar

  10. Hajarizadeh Behzad, Grebely Jason, Dore Gregory J. Epidemiology and natural history of HCV infection. Nature reviews Gastroenterology & hepatology. 2013;10(9):553. PubMed | Google Scholar

  11. Poynard Thierry, Yuen Man-Fung, Ratzin Vlad, Lai Ching Lung. Viral hepatitis C. The Lancet. 2003;362(9401):2095-100. PubMed | Google Scholar

  12. Thomson Emma C, Fleming Vicki M, Main Janice, Klenerman Paul, Weber Jonathan, Eliahoo Joseph et al. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut. 2011;60(6):837-45. PubMed | Google Scholar

  13. Sonderup Mark W, Afihene Mary, Ally Reidwaan, Apica Betty, Awuku Yaw, Cunha Lina et al. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. The Lancet Gastroenterology & Hepatology. 2017;2(12):910-9. PubMed | Google Scholar

  14. Agyeman Akosua Adom, Ofori-Asenso Richard, Mprah Andy, Ashiagbor George. Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis. BMC Infectious Diseases. 2016;16(1):391. PubMed | Google Scholar

  15. Akyar Eda, Mora Nallely, Luke Amy, Layden Jennifer, Phillips Richard, Agyarko-Poku Thomas et al. 2203. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic. Open Forum Infectious Diseases. 2018;5(suppl_1):S650-S. PubMed | Google Scholar

  16. Chan Denise PC, Sun Hsin-Yun, Wong Horas TH, Lee Shui-Shan, Hung Chien-Ching. Sexually acquired hepatitis C virus infection: a review. International Journal of Infectious Diseases. 2016;49:47-58. PubMed | Google Scholar

  17. Agbor Valirie Ndip, Tagny Claude Tayou, Kenmegne Jules-Bertrand, Awazi Bih, Ngansop Charlotte, Mbanya Dora et al. Prevalence of anti-hepatitis C antibodies and its co-infection with HIV in rural Cameroon. BMC Research Notes. 2018;11(1):459. PubMed | Google Scholar

  18. Arya Ravindra, Antonisamy Belavendra, Kumar Sushil. Sample size estimation in prevalence studies. The Indian Journal of Pediatrics. 2012;79(11):1482-8. PubMed | Google Scholar

  19. Lokpo Sylvester Yao, Osei-Yeboah James, Norgbe Gameli Kwame, Owiafe Patrick Kwasi, Ayroe Felix, Ussher Francis Abeku et al. Viral hepatitis Endemicity and trends among an asymptomatic adult population in ho: a 5-year retrospective study at the ho municipal hospital, Ghana. Hepatitis research and treatment. 2017;2017. PubMed | Google Scholar

  20. Apea-Kubi KA, Yamaguchi S, Sakyi B, Ofori-Adjei D. HTLV-1 and other viral sexually transmitted infections in antenatal and gynaecological patients in Ghana. West African journal of medicine. 2006;25(1):17-21. PubMed | Google Scholar

  21. Ephraim Richard, Donko Isaac, Sakyi Samuel A, Ampong Joyce, Agbodjakey Hope. Seroprevalence and risk factors of hepatitis B and hepatitis C infections among pregnant women in the Asante Akim North Municipality of the Ashanti region, Ghana; a cross sectional study. African health sciences. 2015;15(3):709-13. PubMed | Google Scholar

  22. Allain Jean-Pierre, Opare-Sem Ohene, Sarkodie Francis, Rahman Rabiatu, Owusu-Ofori Shirley. Deferred donor care in a regional hospital blood center in Ghana. Transfusion. 2009;49(4):669-75. PubMed | Google Scholar

  23. Terrault Norah A, Dodge Jennifer L, Murphy Edward L, Tavis John E, Kiss Alexi, Levin TR et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013;57(3):881-9. PubMed | Google Scholar

  24. Frempong Margaret T, Ntiamoah Paul, Annani-Akollor Max Efui, Owiredu William KBA, Addai-Mensah Otchere, Owiredu Eddie-Williams et al. Hepatitis B and C infections in HIV-1 and non-HIV infected pregnant women in the Brong-Ahafo Region, Ghana. PloS one. 2019;14(7). PubMed | Google Scholar

  25. Mutocheluh Mohamed, Owusu Michael, Kwofie Theophilus B, Akadigo Tahiru, Appau Emmanuel, Narkwa Patrick W. Risk factors associated with hepatitis B exposure and the reliability of five rapid kits commonly used for screening blood donors in Ghana. BMC research notes. 2014;7(1):873. PubMed | Google Scholar

  26. Rao V Bhargavi, Johari Nur, du Cros Philipp, Messina Janey, Ford Nathan, Cooke Graham S. Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet infectious diseases. 2015;15(7):819-24. PubMed | Google Scholar

  27. Loarec Anne, Carnimeo Valentina, Molfino Lucas, Kizito Walter, Muyindike Winnie, Andrieux-Meyer Isabelle et al. Extremely low hepatitis C prevalence among HIV co-infected individuals in four countries in sub-Saharan Africa. AIDS (London, England). 2019;33(2):353. PubMed | Google Scholar

  28. Tagny Claude Tayou, Mbanya Dora, Murphy Edward L, Lefrère Jean-Jacques, Laperche Syria. Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test. Journal of virological methods. 2014;199:119-23. PubMed | Google Scholar

  29. Mullis Caroline E, Laeyendecker Oliver, Reynolds Steven J, Ocama Ponsiano, Quinn Jeffrey, Boaz Iga et al. High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. Clinical infectious diseases. 2013;57(12):1747-50. PubMed | Google Scholar

  30. Thanaa El A Helal, Danial Moheb F, Ahmed Hassan F. The relationship between hepatitis C virus and schistosomiasis: histopathologic evaluation of liver biopsy specimens. Human pathology. 1998;29(7):743-9. PubMed | Google Scholar

  31. Kalra Gurvinder, Subramanyam Alka, Pinto Charles. Sexuality: Desire, activity and intimacy in the elderly. Indian journal of psychiatry. 2011;53(4):300. PubMed | Google Scholar

  32. Niu ZhiLi, Zhang PingAn, Tong YongQing. Age and gender distribution of Hepatitis C virus prevalence and genotypes of individuals of physical examination in WuHan, Central China. Springerplus. 2016;5(1):1557. PubMed | Google Scholar

  33. Marian I. Butterfield, Hayden B. Bosworth, Keith G. Meador, Karen M. Stechuchak, Susan M. Essock, Fred C. Osher et al. Blood-Borne Infections and Persons With Mental Illness: Gender Differences in Hepatitis C Infection and Risks Among Persons With Severe Mental Illness. Psychiatric Services. 2003;54(6):848-53. PubMed | Google Scholar

  34. Yee Leland J, Weiss Heidi L, Langner Rebecca G, Herrera Jorge, Kaslow Richard A, van Leeuwen Dirk J. Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance. BMC Infectious Diseases. 2001;1(1):8. PubMed | Google Scholar

  35. Akyar Eda, Mora Nallely, Luke Amy, Layden Jennifer, Phillips Richard, Agyarko-Poku Thomas et al. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic. Open Forum Infectious Diseases. 2018;5:S650-S. PubMed | Google Scholar